These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 15993365

  • 1. Identification of prolactin as a novel immunomodulator on the expression of co-stimulatory molecules and cytokine secretions on T and B human lymphocytes.
    Chavez-Rueda K, Hérnández J, Zenteno E, Leaños-Miranda A, Legorreta-Haquet MV, Blanco-Favela F.
    Clin Immunol; 2005 Aug; 116(2):182-91. PubMed ID: 15993365
    [Abstract] [Full Text] [Related]

  • 2. Prolactin effect on CD69 and CD154 expression by CD4+ cells from systemic lupus erythematosus patients.
    Chavez-Rueda K, Legorreta-Haquet MV, Cervera-Castillo H, Sánchez L, Jara LJ, Zenteno E, Blanco-Favela F.
    Clin Exp Rheumatol; 2005 Aug; 23(6):769-77. PubMed ID: 16396693
    [Abstract] [Full Text] [Related]

  • 3. CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A.
    Mukherjee S, Ahmed A, Nandi D.
    J Leukoc Biol; 2005 Jul; 78(1):144-57. PubMed ID: 15788440
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of CD23 hyperexpression on B cells from patients with rheumatoid arthritis.
    De Miguel S, Galocha B, Jover JA, Bañares A, Hernández-García C, García-Asenjo JA, Fernández-Gutiérrez B.
    J Rheumatol; 2001 Jun; 28(6):1222-8. PubMed ID: 11409113
    [Abstract] [Full Text] [Related]

  • 5. Immunoregulation of autocrine prolactin: suppressing the expression of costimulatory molecules and cytokines in T lymphocytes by prolactin receptor knockdown.
    Xu D, Lin L, Lin X, Huang Z, Lei Z.
    Cell Immunol; 2010 Jun; 263(1):71-8. PubMed ID: 20307875
    [Abstract] [Full Text] [Related]

  • 6. Recombinant human erythropoietin treatment of chronic renal failure patients normalizes altered phenotype and proliferation of CD4-positive T lymphocytes.
    Lisowska KA, Debska-Slizien A, Radzka M, Witkowski JM, Rutkowski B, Bryl E.
    Artif Organs; 2010 Mar; 34(3):E77-84. PubMed ID: 20447038
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW, Liao CH, Ying C, Chang CJ, Lin CM.
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [Abstract] [Full Text] [Related]

  • 10. Differential effect of sodium arsenite during the activation of human CD4+ and CD8+ T lymphocytes.
    Tenorio EP, Saavedra R.
    Int Immunopharmacol; 2005 Dec; 5(13-14):1853-69. PubMed ID: 16275621
    [Abstract] [Full Text] [Related]

  • 11. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.
    Guo Z, Zheng C, Chen Z, Gu D, Du W, Ge J, Han Z, Yang R.
    Eur J Immunol; 2009 Oct; 39(10):2840-9. PubMed ID: 19637224
    [Abstract] [Full Text] [Related]

  • 12. Role of the cytokine environment and cytokine receptor expression on the generation of functionally distinct dendritic cells from human monocytes.
    Conti L, Cardone M, Varano B, Puddu P, Belardelli F, Gessani S.
    Eur J Immunol; 2008 Mar; 38(3):750-62. PubMed ID: 18236400
    [Abstract] [Full Text] [Related]

  • 13. Effect of prolactin on lymphocyte activation from systemic lupus erythematosus patients.
    Chavez-Rueda K, Legorreta-Haquet VM, Cervera-Castillo H, Sánchez L, Jara LJ, Zenteno E, Chavez-Sanchez L, Blanco-Favela F.
    Ann N Y Acad Sci; 2007 Jun; 1108():157-65. PubMed ID: 17893982
    [Abstract] [Full Text] [Related]

  • 14. Novel human CD4+ T lymphocyte subpopulations defined by CD300a/c molecule expression.
    Clark GJ, Rao M, Ju X, Hart DN.
    J Leukoc Biol; 2007 Nov; 82(5):1126-35. PubMed ID: 17702825
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dual role of anti-TNF therapy: enhancement of TCR-mediated T cell activation in peripheral blood and inhibition of inflammation in target tissues.
    Bosè F, Raeli L, Garutti C, Frigerio E, Cozzi A, Crimi M, Caprioli F, Scavelli R, Altomare G, Geginat J, Abrignani S, Reali E.
    Clin Immunol; 2011 May; 139(2):164-76. PubMed ID: 21334981
    [Abstract] [Full Text] [Related]

  • 17. Activation-associated phenotype of CD3 T cells in acute graft-versus-host disease.
    Paz Morante M, Briones J, Canto E, Sabzevari H, Martino R, Sierra J, Rodriguez-Sanchez JL, Vidal S.
    Clin Exp Immunol; 2006 Jul; 145(1):36-43. PubMed ID: 16792671
    [Abstract] [Full Text] [Related]

  • 18. Platelets inhibit in vitro response of lymphocytes to mitogens.
    Wang Y, Niu J.
    Immunol Lett; 2008 Aug 15; 119(1-2):57-61. PubMed ID: 18514331
    [Abstract] [Full Text] [Related]

  • 19. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS, Krishnadas DK, Agrawal B.
    Int Immunol; 2007 Mar 15; 19(3):227-37. PubMed ID: 17289657
    [Abstract] [Full Text] [Related]

  • 20. Effect of synthetic agonists of toll-like receptor 9 on canine lymphocyte proliferation and cytokine production in vitro.
    Im Hof M, Williamson L, Summerfield A, Balmer V, Dutoit V, Kandimalla ER, Yu D, Zurbriggen A, Doherr MG, Peel J, Roosje PJ.
    Vet Immunol Immunopathol; 2008 Jul 15; 124(1-2):120-31. PubMed ID: 18452997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.